Investigator-Initiated Clinical Trials Program – Full Application
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with unit
Memorial Deadline: Friday 11th, September 2026
External Deadline: Wednesday 16th, September 2026
Description
The Cancer Research Society (CRS), with the Canadian Cancer Society (CCS) and the Terry Fox Research Institute (TFRI), are launching a new funding opportunity dedicated entirely to investigator-initiated oncology clinical trials in Canada.
With partners – the Lotte & John Hecht Memorial Foundation, Génome Québec, Kindred Foundation and Childhood Cancer Canada – this program aims to enable Canadian researchers to lead groundbreaking trials that can reshape the cancer landscape in Canada and worldwide.
CCS‘s Strategic Plan (2026-2031) calls for clinical trials for more effective cancer prevention, detection and treatment, with the goals of stopping cancer before it starts and increasing cancer survival. Concurrently, priority 7 of CCS’s Clinical Trials Action Plan (CTAP) aims to establish robust and sustainable cancer clinical trial funding in Canada. Therefore, CCS is extremely proud to partner on this inaugural, national program.
For this funding opportunity, CCS and its partners will fund early-stage clinical trials (from proof-of-concept to Phase II) focused in the following areas:
- – Low survival and high incidence cancers, specifically: lung, esophageal, stomach, brain*, liver, ovarian, pancreas, prostate, breast, and/or colorectal cancer – with a goal of developing novel detection approaches/modalities and/or treatments
-
- *Specific partnered funds are available for trials focused on glioblastoma
- – Prevention of cancer, especially for high incidence cancers such as prostate, breast, colorectal and/or lung cancer.
- – As a result of partnership funding, trials utilizing gold – as a diagnostic, drug delivery vehicle, and/or therapeutic enhancer – with a strong potential to improve patient outcomes, influence clinical practice, or advance therapeutic pathways.
- See here for more information.
-
Information webinar:May 1, 2026 (12 to 1 pm EST)Letter of intent deadline:June 4, 2026 (11:59 pm EST)Application deadline:September 16, 2026 (11:59 pm EST)